Recombinant Human SF3B14 protein is a Human Full Length protein, in the 1 to 125 aa range, expressed in Escherichia coli, with >95% purity and suitable for SDS-PAGE, MS.
M G S S H H H H H H S S G L V P R G S H M A M Q A A K R A N I R L P P E V N R I L Y I R N L P Y K I T A E E M Y D I F G K Y G P I R Q I R V G N T P E T R G T A Y V V Y E D I F D A K N A C D H L S G F N V C N R Y L V V L Y Y N A N R A F Q K M D T K K K E E Q L K L L K E K Y G I N T D P P K
Application | Reactivity | Dilution info | Notes |
---|---|---|---|
Application SDS-PAGE | Reactivity Reacts | Dilution info - | Notes - |
Application MS | Reactivity Reacts | Dilution info - | Notes - |
Component of the 17S U2 SnRNP complex of the spliceosome, a large ribonucleoprotein complex that removes introns from transcribed pre-mRNAs (PubMed:12234937, PubMed:27720643, PubMed:32494006, PubMed:34822310). The 17S U2 SnRNP complex (1) directly participates in early spliceosome assembly and (2) mediates recognition of the intron branch site during pre-mRNA splicing by promoting the selection of the pre-mRNA branch-site adenosine, the nucleophile for the first step of splicing (PubMed:12234937, PubMed:32494006, PubMed:34822310). Within the 17S U2 SnRNP complex, SF3B6 is part of the SF3B subcomplex, which is required for 'A' complex assembly formed by the stable binding of U2 snRNP to the branchpoint sequence in pre-mRNA (PubMed:12234937, PubMed:27720643). Sequence independent binding of SF3A and SF3B subcomplexes upstream of the branch site is essential, it may anchor U2 snRNP to the pre-mRNA (PubMed:12234937). Within the 17S U2 SnRNP complex, SF3B6 directly contacts the pre-mRNA branch site adenosine for the first catalytic step of splicing (PubMed:16432215). SF3B6 stabilizes the intron branch site-U2 snRNA duplex, thereby promoting-binding of introns with poor sequence complementarity (PubMed:34822310). Also acts as a component of the minor spliceosome, which is involved in the splicing of U12-type introns in pre-mRNAs (PubMed:15146077, PubMed:33509932).
SAP14, SF3B14, SF3B14A, CGI-110, HSPC175, HT006, SF3B6, Splicing factor 3B subunit 6, Pre-mRNA branch site protein p14, SF3b 14 kDa subunit, SF3B14a
Recombinant Human SF3B14 protein is a Human Full Length protein, in the 1 to 125 aa range, expressed in Escherichia coli, with >95% purity and suitable for SDS-PAGE, MS.
pH: 8
Constituents: 30% Glycerol (glycerin, glycerine), 1.16% Sodium chloride, 0.316% Tris HCl, 0.077% (R*,R*)-1,4-Dimercaptobutan-2,3-diol, 0.0292% EDTA
Purified by using anion-exchange chromatography (DEAE sepharose resin) and gel-filtration chromatography (Sephacryl S-200) with 20mM Tris pH 7.5, 2mM EDTA.
Component of the 17S U2 SnRNP complex of the spliceosome, a large ribonucleoprotein complex that removes introns from transcribed pre-mRNAs (PubMed:12234937, PubMed:27720643, PubMed:32494006, PubMed:34822310). The 17S U2 SnRNP complex (1) directly participates in early spliceosome assembly and (2) mediates recognition of the intron branch site during pre-mRNA splicing by promoting the selection of the pre-mRNA branch-site adenosine, the nucleophile for the first step of splicing (PubMed:12234937, PubMed:32494006, PubMed:34822310). Within the 17S U2 SnRNP complex, SF3B6 is part of the SF3B subcomplex, which is required for 'A' complex assembly formed by the stable binding of U2 snRNP to the branchpoint sequence in pre-mRNA (PubMed:12234937, PubMed:27720643). Sequence independent binding of SF3A and SF3B subcomplexes upstream of the branch site is essential, it may anchor U2 snRNP to the pre-mRNA (PubMed:12234937). Within the 17S U2 SnRNP complex, SF3B6 directly contacts the pre-mRNA branch site adenosine for the first catalytic step of splicing (PubMed:16432215). SF3B6 stabilizes the intron branch site-U2 snRNA duplex, thereby promoting-binding of introns with poor sequence complementarity (PubMed:34822310). Also acts as a component of the minor spliceosome, which is involved in the splicing of U12-type introns in pre-mRNAs (PubMed:15146077, PubMed:33509932).
Belongs to the SF3B6 family.
SF3B14 also known as Splicing Factor 3b Subunit 14 is a component of the splicing factor 3b (SF3b) complex. It has a molecular mass of approximately 14 kDa. SF3B14 is prominently expressed in various tissues with a strong presence in the nucleus where it participates in the spliceosomal machinery. Its mechanical role is to bind and stabilize pre-mRNA as a part of the spliceosome which is essential for proper splicing of precursor mRNA into mature mRNA.
SF3B14 contributes to the precise assembly of the spliceosome complex being a significant component of the SF3b complex. This complex is part of the U2 small nuclear ribonucleoprotein (snRNP) within the spliceosome. SF3B14 alongside other components of the SF3b complex ensures the accurate recognition and removal of introns during gene expression. By facilitating correct splicing it plays a role in regulating gene expression levels and maintaining cell function.
Spliceosomes and their components including SF3B14 play a role in the RNA splicing pathway. This pathway is fundamental for the modification of pre-mRNA into mature and functionally diverse mRNA. Additionally SF3B14 intersects with other spliceosomal proteins such as SF3B1 ensuring correct splice site selection. These interactions facilitate efficient mRNA processing which is essential for the flow of genetic information from DNA to proteins.
Malfunction or dysregulation of SF3B14 has connections with certain cancers including leukemia. Anomalies in the splicing process due to faulty components like SF3B14 can lead to aberrant mRNA and protein products contributing to oncogenic transformation. Additionally SF3B14 has associations with neurodegenerative disorders where disruptions in splicing patterns can affect neural cell survival. The protein SF3B1 closely linked to SF3B14 is often similarly implicated due to their shared roles within the spliceosome.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
15% SDS-PAGE analysis of ab103908 (3 μg)
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com